Targeting the mechano-microenvironment and liver cancer stem cells: a promising therapeutic strategy for liver cancer

被引:11
作者
Fu, Xiaorong [1 ,2 ,3 ]
Zhang, Yi [3 ]
Luo, Qing [2 ]
Ju, Yang [3 ]
Song, Guanbin [2 ]
机构
[1] Guizhou Med Univ, Sch Biol & Engn, Guiyang 550000, Peoples R China
[2] Chongqing Univ, Coll Bioengn, Chongqing 400030, Peoples R China
[3] Nagoya Univ, Dept Mech Sci & Engn, Nagoya 4648603, Japan
基金
中国国家自然科学基金; 日本学术振兴会;
关键词
Liver cancer; mechano-microenvironment; cancer stem cells; tumor heterogeneity; mechanotherapy; EPITHELIAL-MESENCHYMAL TRANSITION; HEPATOCELLULAR-CARCINOMA; TRANSIENT ELASTOGRAPHY; STIFFNESS MEASUREMENT; MATRIX STIFFNESS; INITIATING CELLS; FIBROSIS; BETA; CHEMORESISTANCE; PROGRESSION;
D O I
10.20892/j.issn.2095-3941.2023.0229
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Over the past 2 decades, cancer stem cells (CSCs) have been identified as the root cause of cancer occurrence, progression, chemoradioresistance, recurrence, and metastasis. Targeting CSCs is a novel therapeutic strategy for cancer management and treatment. Liver cancer (LC) is a malignant disease that can endanger human health. Studies are increasingly suggesting that changes in the liver mechanical microenvironment are a primary driver triggering the occurrence and development of liver cancer. In this review, we summarize current understanding of the roles of the liver mechano-microenvironment and liver cancer stem cells (LCSCs) in liver cancer progression. We also discuss the relationship between the mechanical heterogeneity of liver cancer tissues and LCSC recruitment and metastasis. Finally, we highlight potential mechanosensitive molecules in LCSCs and mechanotherapy in liver cancer. Understanding the roles and regulatory mechanisms of the mechano-microenvironment and LCSCs may provide fundamental insights into liver cancer progression and aid in further development of novel therapeutic strategies.
引用
收藏
页码:816 / 829
页数:14
相关论文
共 109 条
[11]   Non-invasive evaluation of liver fibrosis using transient elastography [J].
Castera, Laurent ;
Forns, Xavier ;
Alberti, Alfredo .
JOURNAL OF HEPATOLOGY, 2008, 48 (05) :835-847
[12]   Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations [J].
Castera, Laurent ;
Foucher, Juliette ;
Bernard, Pierre-Henri ;
Carvalho, Francoise ;
Allaix, Daniele ;
Merrouche, Wassil ;
Couzigou, Patrice ;
de Ledinghen, Victor .
HEPATOLOGY, 2010, 51 (03) :828-835
[13]   Deep tumor-penetrated nanosystem eliminates cancer stem cell for highly efficient liver cancer therapy [J].
Chen, Qiufang ;
Deng, Bin ;
Luo, Qing ;
Song, Guanbin .
CHEMICAL ENGINEERING JOURNAL, 2021, 421
[14]   CD133+EpCAM+ Phenotype Possesses More Characteristics of Tumor Initiating Cells in Hepatocellular Carcinoma Huh7 Cells [J].
Chen, Yi ;
Yu, Dongke ;
Zhang, Hao ;
He, Hongwei ;
Zhang, Caixia ;
Zhao, Wuli ;
Shao, Rong-guang .
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2012, 8 (07) :992-1004
[15]   3D hanging spheroid plate for high-throughput CART cell cytotoxicity assay [J].
Chen, Zhenzhong ;
Han, Seokgyu ;
Sanny, Arleen ;
Chan, Dorothy Leung-Kwan ;
van Noort, Danny ;
Lim, Wanyoung ;
Tan, Andy Hee-Meng ;
Park, Sungsu .
JOURNAL OF NANOBIOTECHNOLOGY, 2022, 20 (01)
[16]   The matrix in cancer [J].
Cox, Thomas R. .
NATURE REVIEWS CANCER, 2021, 21 (04) :217-238
[17]   Hepatic microvasculature in liver injury [J].
DeLeve, Laurie D. .
SEMINARS IN LIVER DISEASE, 2007, 27 (04) :390-400
[18]   Physiological Ranges of Matrix Rigidity Modulate Primary Mouse Hepatocyte Function in Part Through Hepatocyte Nuclear Factor 4 Alpha [J].
Desai, Seema S. ;
Tung, Jason C. ;
Zhou, Vivian X. ;
Grenert, James P. ;
Malato, Yann ;
Rezvani, Milad ;
Espanol-Suner, Regina ;
Willenbring, Holger ;
Weaver, Valerie M. ;
Chang, Tammy T. .
HEPATOLOGY, 2016, 64 (01) :261-275
[19]   CCND1 silencing suppresses liver cancer stem cell differentiation and overcomes 5-Fluorouracil resistance in hepatocellular carcinoma [J].
Ding, Hao ;
Wang, Yijun ;
Zhang, Hongying .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2020, 143 (03) :219-225
[20]   MiRNA-mediated EMT and CSCs in cancer chemoresistance [J].
Dong, Bing ;
Li, Shiyu ;
Zhu, Shuangli ;
Yi, Ming ;
Luo, Suxia ;
Wu, Kongming .
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2021, 10 (01)